Follow @TMFMassimo
Recent articles
Drawing Biopharma Concepts With A Crayon
Max Macaluso and Kristine Harjes | May 23, 2016
Peter Lynch once said, “Never invest in any idea you can’t illustrate with a crayon.” Does that hold true in the highly scientific world of biopharma?
Better Stock Today Challenge: InvenSense vs. Seadrill
Max Macaluso and Joel South | Jun 20, 2014
In the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Better Stock Today Challenge: InvenSense vs. DistributionNow
Max Macaluso and Joel South | Jun 18, 2014
In the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Better Stock Today Challenge: InvenSense vs. SodaStream
Max Macaluso and Mark Reeth | Jun 17, 2014
In the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Better Stock Today Challenge: Apple vs. Annaly Capital
Max Macaluso and David Hanson | Jun 17, 2014
In the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Better Stock Today: InvenSense vs. Johnson & Johnson
Max Macaluso and Dave Williamson | Jun 15, 2014
In the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Better Stock Today: Vanguard Natural Resources vs. Apple
Max Macaluso and Joel South | Jun 15, 2014
In the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
This Internet of Things Company is Changing Medicine as We Know It
Max Macaluso and Eric Bleeker | Jun 9, 2014
A look at smart-pill pioneer Proteus Digital Health.
The Biggest Threat to Facebook's $19 Billion WhatsApp Buy
Max Macaluso and Eric Bleeker | Jun 5, 2014
Will smaller, more intimate communication networks like WhatsApp start pulling people away from sprawling ones like Facebook?
Will Your Car Have No Steering Wheel in 5 Years? Google Makes Its Self-Driving-Car Move
Max Macaluso and Eric Bleeker | Jun 4, 2014
Will Google be able to get its driverless car, or at least the tech behind it, into the marketplace? Or will companies not want to play ball with the Internet giant?
Why Is Intel Partnering With a Company You've Probably Never Heard Of?
Max Macaluso and Eric Bleeker | Jun 4, 2014
Tech giant Intel has partnered with the relatively unknown Rockchip in an effort to get its chips into inexpensive smartphones and tablets in emerging markets.
Will Google's Nest Disrupt the Smart Home Industry?
Max Macaluso and Eric Bleeker | Jun 2, 2014
Google Inc.'s Nest thermostat and ADT Corp.'s home security systems are but two of the names filling out the already crowded connected-home market.
What's the Future of the Connected TV?
Max Macaluso and Eric Bleeker | May 31, 2014
A lot of companies are developing new ways to deliver content to your TV, but will the television watching experience really change in the next few years?
AT&T Inc. Dips Its Toes in the Connected Home
Max Macaluso and Eric Bleeker | May 30, 2014
AT&T Inc. is trying to connect consumers' homes with its Digital Life program, but will that in any way affect the company's bottom line?
Understanding Multiple Sclerosis: An Interview With Novartis' Dr. Gordon Francis
Max Macaluso | May 28, 2014
Understanding multiple sclerosis and Novartis' drug Gilenya.
An Interview With Harry Kirsch, CFO of Novartis
Max Macaluso | May 20, 2014
Novartis CFO Harry Kirsch discusses Novartis' culture and its recent deals with GlaxoSmithKline and Eli Lilly.
CannaVEST Corp.: What Investors Need to Watch
Max Macaluso and Michael Douglass | Apr 30, 2014
What investors need to watch at CannaVEST
What's Behind the Biotech Crash?
Max Macaluso and Matt Koppenheffer | Apr 23, 2014
What's the real story behind the rise and fall of the biotech bubble?
Allergan, Inc.: Another Billion-Dollar Buyout Target
Max Macaluso and Michael Douglass | Apr 23, 2014
Valeant might continue its acquisition streak with the hefty purchase of Allergan.
Biotech Banter: FDA Delay, Clinical Trial News, and Tweet of the Week
Max Macaluso and Brian Orelli, PhD | Apr 10, 2014
The latest from The Motley Fool's biotech show "Biotech Banter."